IL-33 inhibits RANKL-induced osteoclast formation through the regulation of Blimp-1 and IRF-8 expression

Biochemical and Biophysical Research Communications

Volumn 460, Issue 2, 2015, Pages 320-326

  Kiyomiya, Hiroyasu ^a   Ariyoshi, Wataru ^a   Okinaga, Toshinori ^a   Kaneuji, Takeshi ^a   Mitsugi, Sho ^a   Sakurai, Takuma ^a   Habu, Manabu ^a   Yoshioka, Izumi ^a   Tominaga, Kazuhiro ^a   Nishihara, Tatsuji ^a  

^a KYUSHU DENTAL COLLEGE   (Japan)

Author keywords

Blimp 1; IL 33; IRF 8; Osteoclastogenesis

Indexed keywords

INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR; INTERLEUKIN DERIVATIVE; INTERLEUKIN-33, MOUSE; NFATC1 PROTEIN, MOUSE; OSTEOCLAST DIFFERENTIATION FACTOR; PRDM1 PROTEIN, MOUSE; PRIMER DNA; TNFSF11 PROTEIN, MOUSE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFAT;

ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CELL LINE; CYTOLOGY; FEMALE; GENETICS; MALE; METABOLISM; MOUSE; NUCLEOTIDE SEQUENCE; OSTEOCLAST; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; BASE SEQUENCE; CELL LINE; CELLS, CULTURED; DNA PRIMERS; FEMALE; INTERFERON REGULATORY FACTORS; INTERLEUKINS; MALE; MICE; NFATC TRANSCRIPTION FACTORS; OSTEOCLASTS; RANK LIGAND; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84937760049     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.03.033     Document Type: Article

References (30)

1. T. Nakashima, M. Hayashi, and H. Takayanagi New insights into osteoclastogenic signalling mechanisms Trends Endocrinol. Metab.: TEM 23 2012 582 590
2. T. Suda, N. Takahashi, N. Udagawa, E. Jimi, M.T. Gillespie, and T.J. Martin Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families Endocr. Rev. 20 1999 345 357
3. B.R. Wong, R. Josien, S.Y. Lee, M. Vologodskaia, R.M. Steinman, and Y. Choi The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor J. Biol. Chem. 273 1998 28355 28359
4. M.C. Walsh, G.K. Kim, P.L. Maurizio, E.E. Molnar, and Y. Choi TRAF6 autoubiquitination-independent activation of the NFkappaB and MAPK pathways in response to IL-1 and RANKL PloS one 3 2008 e4064
5. J. Mizukami, G. Takaesu, H. Akatsuka, H. Sakurai, J. Ninomiya-Tsuji, K. Matsumoto, and N. Sakurai Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6 Mol. Cell. Biol. 22 2002 992 1000
6. H. Takayanagi, S. Kim, T. Koga, H. Nishina, M. Isshiki, H. Yoshida, A. Saiura, M. Isobe, T. Yokochi, J. Inoue, E.F. Wagner, T.W. Mak, T. Kodama, and T. Taniguchi Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts Dev. Cell. 3 2002 889 901
7. J.E. Sims, and D.E. Smith The IL-1 family: regulators of immunity, nature reviews Immunology 10 2010 89 102
8. J. Schmitz, A. Owyang, E. Oldham, Y. Song, E. Murphy, T.K. McClanahan, G. Zurawski, M. Moshrefi, J. Qin, X. Li, D.M. Gorman, J.F. Bazan, and R.A. Kastelein IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines Immunity 23 2005 479 490
9. G. Palmer, D. Talabot-Ayer, C. Lamacchia, D. Toy, C.A. Seemayer, S. Viatte, A. Finckh, D.E. Smith, and C. Gabay Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis Arthritis Rheum. 60 2009 738 749
10. S. Saidi, F. Bouri, P. Lencel, L. Duplomb, M. Baud'huin, S. Delplace, D. Leterme, F. Miellot, D. Heymann, P. Hardouin, G. Palmer, and D. Magne IL-33 is expressed in human osteoblasts, but has no direct effect on bone remodeling Cytokine 53 2011 347 354
11. M.M. Zaiss, M. Kurowska-Stolarska, C. Bohm, R. Gary, C. Scholtysek, B. Stolarski, J. Reilly, S. Kerr, N.L. Millar, T. Kamradt, I.B. McInnes, P.G. Fallon, J.P. David, F.Y. Liew, and G. Schett IL-33 shifts the balance from osteoclast to alternatively activated macrophage differentiation and protects from TNF-alpha-mediated bone loss J. Immunol. 186 2011 6097 6105 (Baltimore, Md.: 1950)
12. H. Takayanagi Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems, nature reviews Immunology 7 2007 292 304
13. M. Komai-Koma, D. Xu, Y. Li, A.N. McKenzie, I.B. McInnes, and F.Y. Liew IL-33 is a chemoattractant for human Th2 cells Eur. J. Immunol. 37 2007 2779 2786
14. B. Stolarski, M. Kurowska-Stolarska, P. Kewin, D. Xu, and F.Y. Liew IL-33 exacerbates eosinophil-mediated airway inflammation J. Immunol. 185 2010 3472 3480 (Baltimore, Md.: 1950)
15. J. Schulze, T. Bickert, F.T. Beil, M.M. Zaiss, J. Albers, K. Wintges, T. Streichert, K. Klaetschke, J. Keller, T.N. Hissnauer, A.S. Spiro, A. Gessner, G. Schett, M. Amling, A.N. McKenzie, A.K. Horst, and T. Schinke Interleukin-33 is expressed in differentiated osteoblasts and blocks osteoclast formation from bone marrow precursor cells J. Bone Mineral Res. 26 2011 704 717 Official J. Am. Soc. Bone Mineral Res.
16. J. Keller, P. Catala-Lehnen, K. Wintges, J. Schulze, T. Bickert, W. Ito, A.K. Horst, M. Amling, and T. Schinke Transgenic over-expression of interleukin-33 in osteoblasts results in decreased osteoclastogenesis Biochem. Biophys. Res. Commun. 417 2012 217 222
17. H. Saleh, D. Eeles, J.M. Hodge, G.C. Nicholson, R. Gu, S. Pompolo, M.T. Gillespie, and J.M. Quinn Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro Endocrinology 152 2011 1911 1922
18. N. Ishida, K. Hayashi, M. Hoshijima, T. Ogawa, S. Koga, Y. Miyatake, M. Kumegawa, T. Kimura, and T. Takeya Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator J. Biol. Chem. 277 2002 41147 41156
19. T. Ishikawa, M. Kamiyama, N. Tani-Ishii, H. Suzuki, Y. Ichikawa, Y. Hamaguchi, N. Momiyama, and H. Shimada Inhibition of osteoclast differentiation and bone resorption by cathepsin K antisense oligonucleotides Mol. Carcinog. 32 2001 84 91
20. J.M. Halleen, S. Raisanen, J.J. Salo, S.V. Reddy, G.D. Roodman, T.A. Hentunen, P.P. Lehenkari, H. Kaija, P. Vihko, and H.K. Vaananen Intracellular fragmentation of bone resorption products by reactive oxygen species generated by osteoclastic tartrate-resistant acid phosphatase J. Biol. Chem. 274 1999 22907 22910
21. H. Miyamoto, T. Suzuki, Y. Miyauchi, R. Iwasaki, T. Kobayashi, Y. Sato, K. Miyamoto, H. Hoshi, K. Hashimoto, S. Yoshida, W. Hao, T. Mori, H. Kanagawa, E. Katsuyama, A. Fujie, H. Morioka, M. Matsumoto, K. Chiba, M. Takeya, Y. Toyama, and T. Miyamoto Osteoclast stimulatory transmembrane protein and dendritic cell-specific transmembrane protein cooperatively modulate cell-cell fusion to form osteoclasts and foreign body giant cells J. Bone Mineral Res. 27 2012 1289 1297 Official J. Am. Soc. Bone Mineral Res.
22. M. Asagiri, K. Sato, T. Usami, S. Ochi, H. Nishina, H. Yoshida, I. Morita, E.F. Wagner, T.W. Mak, E. Serfling, and H. Takayanagi Autoamplification of NFATc1 expression determines its essential role in bone homeostasis J. Exp. Med. 202 2005 1261 1269
23. H. Takatsuna, M. Asagiri, T. Kubota, K. Oka, T. Osada, C. Sugiyama, H. Saito, K. Aoki, K. Ohya, H. Takayanagi, and K. Umezawa Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1 J. Bone Mineral Res. 20 2005 653 662 Official J. Am. Soc. Bone Mineral Res.
24. B. Zhao, M. Takami, A. Yamada, X. Wang, T. Koga, X. Hu, T. Tamura, K. Ozato, Y. Choi, L.B. Ivashkiv, H. Takayanagi, and R. Kamijo Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis Nat. Med. 15 2009 1066 1071
25. K. Kim, J.H. Kim, J. Lee, H.M. Jin, H. Kook, K.K. Kim, S.Y. Lee, and N. Kim MafB negatively regulates RANKL-mediated osteoclast differentiation Blood 109 2007 3253 3259
26. K.H. Park-Min, E.Y. Lee, N.K. Moskowitz, E. Lim, S.K. Lee, J.A. Lorenzo, C. Huang, A.M. Melnick, P.E. Purdue, S.R. Goldring, and L.B. Ivashkiv Negative regulation of osteoclast precursor differentiation by CD11b and beta2 integrin-B-cell lymphoma 6 signaling J. Bone Mineral Res. 28 2013 135 149 Official J. Am. Soc. Bone Mineral Res.
27. G. Martins, and K. Calame Regulation and functions of Blimp-1 in T and B lymphocytes Annu. Rev. Immunol. 26 2008 133 169
28. K. Nishikawa, T. Nakashima, M. Hayashi, T. Fukunaga, S. Kato, T. Kodama, S. Takahashi, K. Calame, and H. Takayanagi Blimp1-mediated repression of negative regulators is required for osteoclast differentiation Proc. Natl. Acad. Sci. U. S. A. 107 2010 3117 3122
29. Y. Miyauchi, K. Ninomiya, H. Miyamoto, A. Sakamoto, R. Iwasaki, H. Hoshi, K. Miyamoto, W. Hao, S. Yoshida, H. Morioka, K. Chiba, S. Kato, T. Tokuhisa, M. Saitou, Y. Toyama, T. Suda, and T. Miyamoto The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis J. Exp. Med. 207 2010 751 762
30. W. Kantakamalakul, A.D. Politis, S. Marecki, T. Sullivan, K. Ozato, M.J. Fenton, and S.N. Vogel Regulation of IFN consensus sequence binding protein expression in murine macrophages J. Immunol. 162 1999 7417 7425 (Baltimore, Md.: 1950)